Lilly partners with AC Immune for Alzheimer's treatment


REUTERS: U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease. There is a desperate need for a treatment for Alzheimer's disease.



from Biotech News